Research has already shown that taking anabolic steroids is associated with high blood pressure and an increased risk of developing heart conditions such as left ventricular hypertrophy. Now research, part-funded by the British Heart Foundation and presented at this year’s British Cardiovascular Society conference, June 6-8 in Manchester, England, has shown that for some people misusing steroids can be particularly dangerous.

CorMatrix Cardiovascular Inc. announced the treatment of the first patients using its CorMatrix Tyke, a product specifically designed and cleared for cardiac tissue repairs in neonates and infants. The product received U.S. Food and Drug Administration (FDA) 510(k) clearance in February 2016.

Researchers at Thomas Jefferson University have discovered how to enhance the effectiveness of beta-blockers for heart failure patients by tapping an alternate pathway that both blocks damage to the heart and helps it keep pumping.

St. Jude Medical Inc. recently announced the company received an Innovation Award for its HeartMate 3 Left Ventricular Assist System (LVAS) at the 2016 CardioStim EHRA Europace International Congress of electrophysiology and cardiac technology.